SAM
Sectoral Asset Management’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Buy |
3,471
+1,380
| +66% | +$238K | 0.4% | 63 |
|
|
2025
Q1 | $326K | Buy |
2,091
+491
| +31% | +$76.5K | 0.25% | 60 |
|
|
2024
Q4 | $220K | Sell |
1,600
-541
| -25% | -$74.5K | 0.15% | 72 |
|
|
2024
Q3 | $320K | Sell |
2,141
-525
| -20% | -$78.4K | 0.19% | 74 |
|
|
2024
Q2 | $364K | Sell |
2,666
-1,345
| -34% | -$183K | 0.15% | 75 |
|
|
2024
Q1 | $606K | Sell |
4,011
-430
| -10% | -$65K | 0.24% | 61 |
|
|
2023
Q4 | $559K | Buy |
4,441
+200
| +5% | +$25.2K | 0.24% | 73 |
|
|
2023
Q3 | $397K | Buy |
4,241
+1,445
| +52% | +$135K | 0.08% | 110 |
|
|
2023
Q2 | $250K | Buy |
2,796
+1,106
| +65% | +$98.7K | 0.04% | 117 |
|
|
2023
Q1 | $181K | Hold |
1,690
| – | – | 0.03% | 113 |
|
|
2022
Q4 | $206K | Sell |
1,690
-200
| -11% | -$24.4K | 0.04% | 112 |
|
|
2022
Q3 | $195K | Hold |
1,890
| – | – | 0.04% | 103 |
|
|
2022
Q2 | $176K | Sell |
1,890
-4,239
| -69% | -$395K | 0.04% | 105 |
|
|
2022
Q1 | $719K | Hold |
6,129
| – | – | 0.13% | 91 |
|
|
2021
Q4 | $825K | Sell |
6,129
-32,521
| -84% | -$4.38M | 0.12% | 94 |
|
|
2021
Q3 | $6.16M | Buy |
38,650
+35,100
| +989% | +$5.59M | 0.51% | 80 |
|
|
2021
Q2 | $467K | Buy |
3,550
+300
| +9% | +$39.5K | 0.04% | 116 |
|
|
2021
Q1 | $419K | Buy |
+3,250
| New | +$419K | 0.03% | 105 |
|
|
2016
Q2 | – | Sell |
-31,100
| Closed | -$577K | – | 67 |
|
|
2016
Q1 | $577K | Hold |
31,100
| – | – | 0.03% | 78 |
|
|
2015
Q4 | $570K | Hold |
31,100
| – | – | 0.02% | 74 |
|
|
2015
Q3 | $550K | Sell |
31,100
-204,460
| -87% | -$3.62M | 0.03% | 74 |
|
|
2015
Q2 | $4.17M | Sell |
235,560
-496,100
| -68% | -$8.77M | 0.17% | 55 |
|
|
2015
Q1 | $12.7M | Buy |
+731,660
| New | +$12.7M | 0.48% | 47 |
|